Free Nairobi delivery on orders over KES 3,000 · Same-day delivery in Nairobi · Talk to a licensed pharmacist · 7 days a week

Baricinix (Baricitinib) 4mg tablets 30's

Baricitinib is typically prescribed for adults who have moderate to severe rheumatoid arthritis that has not responded well to other treatments, such as methotrexate. It can be used alone or in combination with other medications.
Prescription requiredThis product is a prescription medicine. Upload a valid prescription during checkout.
KES 9,036

Available to order. Not in stock right now — we'll source it and deliver once it arrives.

Prescription required. Add to cart and upload a valid prescription at checkout.

Genuine, PPB-licensed
Same-day delivery in Nairobi
Pharmacist-verified
Have a question? Talk to a pharmacist on WhatsApp

About this product

Baricitinib, marketed under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis and atopic dermatitis. It belongs to a class of medications known as Janus kinase inhibitors (JAK inhibitors), which work by blocking certain enzymes in the body that are involved in the inflammation process. In the case of atopic dermatitis, baricitinib is prescribed for adults who have moderate to severe forms of the condition and have not responded well to topical treatments or other systemic therapies. As with any medication, baricitinib can cause side effects, including an increased risk of infections, changes in blood cell counts, liver enzyme elevations, and an increased risk of blood clots. Therefore, it's crucial to use this medication under the supervision of a healthcare professional who can monitor for any adverse effects and adjust the treatment plan as needed. It's important to follow your healthcare provider's instructions carefully when taking baricitinib and to report any side effects or concerns promptly. Additionally, regular monitoring of your condition and laboratory tests may be necessary while taking this medication.

What it's used for

® is a Janus kinase (JAK) inhibitor indicated for: the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inade

Source: openFDA. For information only — not a substitute for professional medical advice.

Customer reviews

No reviews yet. Be the first to share your experience.

Questions & Answers

No questions yet. Be the first to ask.

Ask a pharmacistReply in minutes · 7 days